MEF2C - myocyte enhancer factor 2C Gene
Also Known as NEDHSIL; DEL5q14.3; C5DELq14.3
Species: Homo sapiens
About MEF2C
This gene has 56 transcripts (splice variants), 271 orthologues, 4 paralogues and is associated with 3 phenotypes. Broad expression in brain (RPKM 55.2), lymph node (RPKM 17.7) and 19 other tissues.
Summary
This locus encodes a member of the MADS box transcription enhancer factor 2 (MEF2) family of proteins, which play a role in myogenesis. The encoded protein, MEF2 polypeptide C, has both trans-activating and DNA binding activities. This protein may play a role in maintaining the differentiated state of muscle cells. Mutations and deletions at this locus have been associated with severe cognitive disability, stereotypic movements, epilepsy, and cerebral malformation. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2010]
MEF2C Products (36)
| mRNA | Protein | Name |
|---|---|---|
| NM_001131005.2 | NP_001124477.1 | myocyte-specific enhancer factor 2C isoform 2 |
| NM_001193347.1 | NP_001180276.1 | myocyte-specific enhancer factor 2C isoform 3 |
| NM_001193348.1 | NP_001180277.1 | myocyte-specific enhancer factor 2C isoform 4 |
| NM_001193349.3 | NP_001180278.1 | myocyte-specific enhancer factor 2C isoform 5 |
| NM_001193350.2 | NP_001180279.1 | myocyte-specific enhancer factor 2C isoform 1 |
| NM_001308002.3 | NP_001294931.1 | myocyte-specific enhancer factor 2C isoform 6 |
| NM_001363581.2 | NP_001350510.1 | myocyte-specific enhancer factor 2C isoform 7 |
| NM_001364329.2 | NP_001351258.1 | myocyte-specific enhancer factor 2C isoform 1 |
| NM_001364330.2 | NP_001351259.1 | myocyte-specific enhancer factor 2C isoform 1 |
| NM_001364331.2 | NP_001351260.1 | myocyte-specific enhancer factor 2C isoform 1 |
| NM_001364332.2 | NP_001351261.1 | myocyte-specific enhancer factor 2C isoform 5 |
| NM_001364333.2 | NP_001351262.1 | myocyte-specific enhancer factor 2C isoform 6 |
| NM_001364334.2 | NP_001351263.1 | myocyte-specific enhancer factor 2C isoform 7 |
| NM_001364335.2 | NP_001351264.1 | myocyte-specific enhancer factor 2C isoform 7 |
| NM_001364336.2 | NP_001351265.1 | myocyte-specific enhancer factor 2C isoform 7 |
| NM_001364337.2 | NP_001351266.1 | myocyte-specific enhancer factor 2C isoform 7 |
| NM_001364338.2 | NP_001351267.1 | myocyte-specific enhancer factor 2C isoform 8 |
| NM_001364339.2 | NP_001351268.1 | myocyte-specific enhancer factor 2C isoform 9 |
| NM_001364340.2 | NP_001351269.1 | myocyte-specific enhancer factor 2C isoform 9 |
| NM_001364341.2 | NP_001351270.1 | myocyte-specific enhancer factor 2C isoform 9 |
| NM_001364342.2 | NP_001351271.1 | myocyte-specific enhancer factor 2C isoform 9 |
| NM_001364343.2 | NP_001351272.1 | myocyte-specific enhancer factor 2C isoform 10 |
| NM_001364344.2 | NP_001351273.1 | myocyte-specific enhancer factor 2C isoform 11 |
| NM_001364345.2 | NP_001351274.1 | myocyte-specific enhancer factor 2C isoform 12 |
| NM_001364346.2 | NP_001351275.1 | myocyte-specific enhancer factor 2C isoform 12 |
| NM_001364347.2 | NP_001351276.1 | myocyte-specific enhancer factor 2C isoform 12 |
| NM_001364348.2 | NP_001351277.1 | myocyte-specific enhancer factor 2C isoform 13 |
| NM_001364349.2 | NP_001351278.1 | myocyte-specific enhancer factor 2C isoform 13 |
| NM_001364350.2 | NP_001351279.1 | myocyte-specific enhancer factor 2C isoform 13 |
| NM_001364352.2 | NP_001351281.1 | myocyte-specific enhancer factor 2C isoform 14 |
| NM_001364353.2 | NP_001351282.1 | myocyte-specific enhancer factor 2C isoform 15 |
| NM_001364354.2 | NP_001351283.1 | myocyte-specific enhancer factor 2C isoform 16 |
| NM_001364355.2 | NP_001351284.1 | myocyte-specific enhancer factor 2C isoform 16 |
| NM_001364356.2 | NP_001351285.1 | myocyte-specific enhancer factor 2C isoform 17 |
| NM_001364357.2 | NP_001351286.1 | myocyte-specific enhancer factor 2C isoform 18 |
| NM_002397.5 | NP_002388.2 | myocyte-specific enhancer factor 2C isoform 1 |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in cytoplasm |
IDA
IDA: Inferred from direct assay
|
8455629 | GOA |
| located in nuclear speck |
IDA
IDA: Inferred from direct assay
|
18079734 | GOA |
| located in nucleus |
IDA
IDA: Inferred from direct assay
|
8455629 | GOA |
| part of protein-containing complex |
IDA
IDA: Inferred from direct assay
|
15486975 | GOA |
MEF2C Protein Structure
SRF-TF: SRF-type transcription factor (DNA-binding and dimerisation domain) (10 - 59)
HJURP_C: Holliday junction regulator protein family C-terminal repeat (95 - 155)
- 0
- 100
- 200
- 300
- 400
- 473 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
myocyte-specific enhancer factor 2C |
|
MEF2C Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
MEF2C | Q06413 | CACNA1C | Homo sapiens | Q13936 | 37207277 | |
|
Intra
|
MEF2C | Q06413 | MYLK2 | Homo sapiens | Q9H1R3 | 21556048 | |
|
Intra
|
MEF2C | Q06413 | HDAC5 | Homo sapiens | Q9UQL6 | 20211142 | |
|
Intra
|
MEF2C | Q06413 | HDAC9 | Homo sapiens | Q9UKV0 | 20936779 | |
|
Intra
|
MEF2C | Q06413 | HDAC9 | Homo sapiens | Q9UKV0 | 20211142 |
MEF2C Antibodies
| Cat. No. | Product Name | Application | Reactivity |
|---|---|---|---|
| HY-P81693 | MEF2C Antibody (YA1438) | WB, IHC-P | Human, Rat |
| HY-P84495 | MEF2C Antibody (YA4192) | WB, IHC-P, FC, ELISA | Human, Mouse, Rat, Rabbit, Monkey |
| HY-P84495A | MEF2C Antibody (YA4192)(PBS only) | WB, IHC-P, FC, ELISA | Human, Mouse, Rat, Rabbit, Monkey |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Neurodevelopmental Disorder With Hypotonia, Stereotypic Hand Movements, And Impaired Language |
|
|
| Autism Spectrum Disorder |
|
|
| Frontotemporal Dementia |
|
|
| Double Outlet Right Ventricle |
|
|
| Developmental And Epileptic Encephalopathy 30 |
|
|
| Rett Syndrome |
|
|
| Prion Disease |
|
|
| Epilepsy |
|
|
| Myoclonic Epilepsy, Juvenile 4 |
|
|
| Hypotonia |
|
|
| Heart Septal Defect |
|
|
| Cerebral Cavernous Malformations |
|
|
| Brachydactyly, Type E1 |
|
|
| Tricuspid Atresia |
|
|
| Pitt-Hopkins Syndrome |
|
|
| Atrioventricular Septal Defect |
|
|
| Van Buchem Disease |
|
|
| Mowat-Wilson Syndrome |
|
|
| Ventricular Septal Defect |
|
|
| Cardiomyopathy, Familial Hypertrophic, 1 |
|
|
| Osteoporosis |
|
|
| Atrial Heart Septal Defect |
|
|
| Myocardial Infarction |
|
|
| Hypoplastic Left Heart Syndrome |
|
|
| Lipoprotein Quantitative Trait Locus |
|
|
| Tetralogy Of Fallot |
|
|
| West Syndrome |
|
|
| Hypertrophic Cardiomyopathy |
|
|
| Dilated Cardiomyopathy |
|
|
| Congenital Nervous System Abnormality |
|
|
| Retinitis Pigmentosa |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Mus musculus | MEF2C | MGD | MGI:99458 |
| Rattus norvegicus | MEF2C | RGD | RGD:1563119 |
| Macaca mulatta | MEF2C | VGNC | VGNC:84438 |
| Canis familiaris | MEF2C | VGNC | VGNC:43144 |
| Felis catus | MEF2C | VGNC | VGNC:102254 |
| Bos taurus | MEF2C | VGNC | VGNC:31373 |
| Others | MEF2C | NCBI |